S031 Dermatology Review: General
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
This session will review the current state of knowledge, evaluation, and treatment of atopic dermatitis, itch, hidradenitis suppurativa, autoimmune blistering diseases, lupus, dermatomyositis, and new recommendations for vaccination for adults receiving biologics and oral therapies.
LEARNING OBJECTIVES
Evaluate the latest advances in pathophysiology for atopic dermatitis, itch, hidradenitis suppurativa, autoimmune blistering diseases, cutaneous lupus erythematosus, and dermatomyositis.
Determine new approaches to evaluation of atopic dermatitis, itch, hidradenitis suppurativa, autoimmune blistering diseases, cutaneous lupus erythematosus, and dermatomyositis, and discuss new vaccination recommendations for adults receiving biologics and oral therapies.
Review current treatments and new developments for atopic dermatitis, itch, hidradenitis suppurativa, autoimmune blistering diseases, cutaneous lupus erythematosus, dermatomyositis
SCHEDULE
6:00 PM
Update on Atopic dermatitis
Lisa A Beck, MD, FAAD
6:30 PM
Update on Itch and its treatments
Brian S Kim, MD, FAAD
7:00 PM
Hidradenitis Suppurativa
Haley Naik, MD, FAAD
7:30 PM
Update on Bullous Diseases
Mary M Tomayko, MD, PhD, FAAD
8:00 PM
Update in Cutaneous lupus and Dermatomyositis
Victoria P. Werth, MD, FAAD
8:30 PM
Vaccination recommendations for adults receiving biologics and oral therapies
Christoph Ellebrecht, MD, FAAD
SPEAKERS
Lisa A Beck, MD, FAAD
Christoph Ellebrecht, MD, FAAD
Brian S Kim, MD, FAAD
Haley Naik, MD, FAAD
Mary M Tomayko, MD, PhD, FAAD
Victoria P. Werth, MD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Lisa A Beck, MD, FAAD
AbbVie – Consultant(Fees), Investigator(Grants/Research Funding); Allakos – Advisory Board(Honoraria); AMGEN – Consultant (1099 relationship)(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); Arena Pharmaceuticals – Advisory Board(Honoraria); ASLAN Pharmaceuticals – Consultant (1099 relationship)(Honoraria); AstraZeneca – Consultant(Fees), Investigator(Grants/Research Funding); Astria Therapeutics – Consultant (1099 relationship)(Honoraria); Belharra Therapeutics – Consultant (1099 relationship)(Honoraria); Celldex – Consultant (1099 relationship)(Honoraria); Dermavent – Consultant (1099 relationship)(Honoraria); Eli Lilly and Company – Consultant(Fees); Escient Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Galderma Research & Development, LLC – Advisory Board(Honoraria); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Honoraria); Invea Therapeutics – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Consultant(Fees); Medtronics – Stockholder(Stock); Merck & Co., Inc – Advisory Board(Honoraria); Nektar Therapeutics – Advisory Board(Honoraria); Novartis – Consultant(Fees); NUMAB Therapeutics AG – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Fees), Investigator(Grants/Research Funding); RAPT Therapeutics – Consultant(Honoraria); Regeneron – Consultant(Fees); Regeneron Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); ResVita Bio, Inc – Consultant (1099 relationship)(Honoraria); Ribon Therapeutics – Consultant(Honoraria); Sanofi – Consultant(Fees), Investigator(Grants/Research Funding); Sitryx Therapeutics – Consultant (1099 relationship)(Honoraria); Stealth Biotherapeutics – Consultant (1099 relationship)(Honoraria); TRex Bio – Consultant (1099 relationship)(Honoraria); Triveni Bio – Consultant (1099 relationship)(Honoraria); UCB Pharma – Consultant (1099 relationship)(Honoraria); Union Therapeutics – Consultant (1099 relationship)(Honoraria); Xencor – Consultant (1099 relationship)(Honoraria);
Christoph Ellebrecht, MD, FAAD
Cabeletta Bio – Founder(Stock);
Brian S Kim, MD, FAAD
23andMe – Consultant (1099 relationship)(Fees); AbbVie – Consultant(Fees); Almirall – Advisory Board(Honoraria); Amagma Therapeutics – Consultant(Fees); Amgen – Consultant (1099 relationship)(Fees); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); AstraZeneca – Consultant (1099 relationship)(Fees); Bellus Health – Advisory Board(Honoraria); Blueprint Medicines – Board of Directors(Honoraria); BMS – Consultant(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria); Cara Therapeutics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Clexio – Consultant (1099 relationship)(Fees); Daewoong Pharmaceuticals – Consultant(Fees); Eli Lilly and Company – Advisory Board(Honoraria); Escient Pharmaceuticals, Inc – Consultant (1099 relationship)(Fees); Evommune, Inc. – Consultant (1099 relationship)(Fees); Galderma – Consultant (1099 relationship)(Fees); Genentech, Inc. – Consultant (1099 relationship)(Fees); GlaxoSmithKline – Consultant (1099 relationship)(Fees); Granular Therapeutics – Consultant(Fees); Guidepoint Global, LLC – Consultant(Fees); Incyte Corporation – Consultant(Fees); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria); Klirna – Founder(Stock); Klirna Biotech, Inc. – Founder(Stock); Leo Pharma Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Locus Biosciences – Stockholder(Stock); Micreos – Consultant (1099 relationship)(Fees); Novartis – Advisory Board(Honoraria); Nuogen Pharma – Founder(Stock); OM Pharma – Consultant(Fees); Pfizer Inc. – Consultant(Honoraria); Recens Medical – Consultant(Fees); Sanofi – Consultant(Fees); Sanofi Genzyme – Consultant(Fees); Sanofi/Regeneron – Advisory Board(Honoraria); Septerna – Consultant (1099 relationship)(Fees); Shaperon – Consultant(Fees); Teva Pharmaceuticals USA – Advisory Board(Fees); Trevi Therapeutics – Consultant(Fees); VeraDermics Inc. – Investigator(Fees);
Haley Naik, MD, FAAD
23andMe – Consultant(Honoraria); AbbVie – Consultant(Honoraria), Other(Grants/Research Funding); Aristea Therapeutics, Inc. – Consultant(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria); Dava Oncology – Consultant(Honoraria); Johnson and Johnson – Consultant(Honoraria); Medscape – Consultant (1099 relationship)(Fees); Nimbus Therapeutics – Consultant(Honoraria); Novartis – Consultant (1099 relationship)(Fees); Radera Biotherapeutics, Inc. – Stockholder Private Company(Stock Options); Radera, Inc. – Stockholder Private Company(Stock Options); Sonoma Biotherapeutics – Consultant (1099 relationship)(Fees); UCB – Consultant (1099 relationship)(Fees);
Mary M Tomayko, MD, PhD, FAAD
Astra Zeneca – Advisory Board(Honoraria); Cabaletta Bio – Investigator(Grants/Research Funding); Immunovant – Consultant (1099 relationship)(Honoraria); Otsuka Pharmaceutical Co., Ltd. – Consultant (1099 relationship)(Honoraria);
Victoria P. Werth, MD, FAAD
Amgen – Investigator(Grants/Research Funding); AnaptysBio – Consultant(Honoraria); arGEN-X – Consultant(Honoraria), Investigator(Grants/Research Funding); argenx – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); AstraZeneca – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); Atticus Pharma, Inc. – Consultant (1099 relationship)(Honoraria); Biogen – Consultant(Honoraria), Investigator(Grants/Research Funding); BMS – Consultant(Honoraria); Cabaletta Bio – Consultant (1099 relationship)(Honoraria); Corbus Pharmaceuticals – Investigator(Grants/Research Funding); CSL Behring – Consultant(Honoraria), Investigator(Grants/Research Funding); Cugene – Consultant(Honoraria); EMD Serono – Consultant(Honoraria); Everest Clinical Research – Consultant (1099 relationship)(Honoraria); Exo Therapeutics – Consultant (1099 relationship)(Honoraria); Gilead Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); GlaxoSmithKline – Consultant(Honoraria); Horizon Pharma, Inc. – Investigator(Grants/Research Funding); Immunovant – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); Kyowa Hakko Kirin Pharma, Inc. – Consultant(Honoraria); Lilly ICOS LLC – Consultant(Honoraria); Lumanity – Consultant (1099 relationship)(Honoraria); Lupus Foundation of America – Consultant(Honoraria); Merck & Co., Inc – Consultant(Honoraria); Novartis – Advisory Board(Honoraria); Nuvig Therapeutics – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Priovant Therapeutics – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); ROME Therapeutics – Consultant(Honoraria); Sanofi Aventis – Consultant(Honoraria); UCB – Consultant(Honoraria); Ventus Therapeutics – Investigator(Grants/Research Funding); Viela Bio – Consultant(Honoraria), Investigator(Grants/Research Funding); Vindico Medical Education – Speaker/Faculty Education(Honoraria);